-
·
Tim’s Multiple Myeloma Story
Tim H., Multiple Myeloma Symptoms: None that could be identified; cancer found through CT scan for gallbladder removal Treatments: Chemotherapy, stem cell transplant
-
·
Significant Disparity: Myeloma Real-World Results Show Striking Contrast with Clinical Trials
Worse Outcomes for Myeloma Patients in Real-World Results vs. Clinical Trials Multiple myeloma patient outcomes are strikingly different in the real-world versus controlled environments according to data presented at the ASH Conference 2023 (Abstract 541). In the real world, multiple myeloma patients demonstrated a 44% reduction in progression-free survival (PFS) and a 75% decrease in…
-
·
FDA Approves New Treatment Options for Relapsed/Refractory Multiple Myeloma Patients
FDA Approves New Treatment Option for Relapsed/Refractory Multiple Myeloma Patients
-
·
The Role of Bispecific Antibodies in the Treatment of Multiple Myeloma
The Role of Bispecific Antibodies in the Treatment of Multiple Myeloma Hematologist Alfred Garfall, MD, MS, from Penn Medicine discusses with multiple myeloma patient advocate Jack Aiello the advancement of immunotherapy for multiple myeloma, the difference between CAR T-cell therapy & bispecific antibodies, and the role of bispecifics in the myeloma toolkit of immunotherapies.
